Oral drug tested for tough skin conditions halted early
NCT ID NCT06555328
First seen Feb 03, 2026 · Last updated Apr 12, 2026 · Updated 8 times
Summary
This study tested an oral medication called INF904 in adults with moderate to severe chronic hives or hidradenitis suppurativa (a painful skin condition). The main goal was to check the drug's safety and how it moves through the body over a 28-day treatment period. The trial was terminated and did not complete its planned course.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIDRADENITIS SUPPURATIVA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
"Cityclinic Przychodnia Lekarsko-Psychologiczna Matusiak Spolka Partnerska"
Wroclaw, 50-566, Poland
-
"Institut Allergieforschung Charité - Universitatsmedizin Berlin"
Berlin, 12203, Germany
-
"Klinikum der Universitat (LMU) Klinik und Poliklinik far Dermatologie und Allergologie"
München, 80337, Germany
-
ASMC IPSMC Skin and Venereal Diseases,
Sofia, 1407, Bulgaria
-
Dawes Fretzin Clinical Research Group, LLC
Indianapolis, Indiana, 46250, United States
-
First OC Dermatology Research Inc.
Fountain Valley, California, 92708, United States
-
ForCare Clinical Research
Tampa, Florida, 33613, United States
-
Forest Hills Dermatology Group
Kew Gardens, New York, 11415, United States
-
General Hospital of Thessaloniki "Papageorgiou"
Thessaloniki, 56403, Greece
-
General University Hospital "Attikon"
Athens, 12462, Greece
-
Katholisches Klinikum Bochum gGmbH/ St.Josef-Hospital Bochum, Dermatologie
Bochum, 44791, Germany
-
Kentucky Advanced Medical Research LLC
Murray, Kentucky, 42071, United States
-
Klinika Dermatologii, Wenerologii i Alergologii, UNIWERSYTECKIE CENTRUM KLINICZNE, ul.
Gdansk, 80-214, Poland
-
LLC "Aversi Clinic"
Tbilisi, 0160, Georgia
-
LLC "Center of Allergy and Immunology"
Tbilisi, 0159, Georgia
-
LTD "Health"
Batumi, 6010, Georgia
-
LTD "Israel-Georgian Medical Research Clinic Healthycore"
Tbilisi, 0112, Georgia
-
Labderm Essence sp.
Ossy, 42-624, Poland
-
MediSearch LLC
Saint Joseph, Missouri, 64506, United States
-
Medical Center Etika
Plovdiv, 4200, Bulgaria
-
Medical Center Excelsior OOD,
Sofia, 1407, Bulgaria
-
Medical Center Medconsult pleven OOD
Pleven, 5800, Bulgaria
-
Medical Center Medconsult, Pleven OOD
Lovech, 5500, Bulgaria
-
Oddziat Kliniczny Wewnetrznych, Astmy i Alergii z Odcinkiem dla Dzieci, Samodzielny Publiczny Zaktad Opieki Zdrowotnej Uniwersytecki Szpital Kliniczny
Lodz, 90-153, Poland
-
Progressive Clinical Research, PA
Texas City, Texas, 78213, United States
-
Universitatsklinikum Dresden Carl Gustav Carus
Dresden, 01307, Germany
-
Universitätsklinikum Frankfurt, Klinik für Dermatologie, Venerologie und Allergologie
Frankfurt, 60950, Germany
-
Wright State Physicians
Fairborn, Ohio, 45324, United States
-
Ziaderm Research LLC
North Miami Beach, Florida, 33162, United States
Conditions
Explore the condition pages connected to this study.